Mycoplasma

Over the years, ELITechGroup has gained expertise and knowledge in urogenital mycoplasma diagnosis and offers a wide range of diagnostic kits for the culture, screening, identification or antibiotic susceptibility testing. Latest innovation in the MYCOFAST® range, the RevolutioN kit includes a number of major innovations enhancing flexibility and ease of use:

  • Antibiotics FULLY compliant with new worldwide recommendations
  • Specimen preserved up to 72 hours before analysis
  • Visual colorimetric method, without expert interpretation 2 approaches available: SCREENING or DIRECT
  • New closing system for secure operation
  • Ready to use reagents
  • Results in accordance with pathological ratios
  • Components available separately  
Products

MYCOFAST® RevolutioN

Detection, enumeration, identification and complete antimicrobial susceptibility testing of urogenital mycoplasma: DIRECT METHOD

The MYCOFAST® RevolutioN is an accurate, cost-effective, easy-to-use colorimetric assay designed for the detection, enumeration, identification and antibiotic susceptibility determination of Ureaplasma urealyticum (U.u.) and Mycoplasma hominis (M.h.) from urogenital specimens.

The MYCOFAST® RevolutioN enables labs to determine susceptibility to a panel of new antibiotics, helping physicians comply with the latest therapeutic guidelines from CLSI (Clinical Laboratories Standards Institute). The addition of the MYCOFAST® RevolutioN expands ELITech’s family of mycoplasma test solutions, offering the most extensive antibiotic susceptibility determination at key clinical end-points.

  • All-in-one test
  • Antibiotics FULLY compliant with new worldwide recommendations
  • Fast results for clinicians, available within 24 hours
  • Visual colorimetric method, without expert interpretation
  • Specimen preserved up to 72 hours before analysis
  • Ready to use reagents, “all-liquid method”
  • New closing system for secure operation
  • Results in accordance with pathological ratios

Featuring ready-to-use reagents and an “all liquid” method, MYCOFAST® RevolutioN identifies the growth of U.u. and M.h. after 24 hours of incubation. Our exclusive growth activator, the M.h. Supplement, guarantees fast and accurate results.
Moreover, MYCOFAST® RevolutioN enables the enumeration of U.u.  > 103 UCC/mL which is compliant with pathological thresholds recognized for sperm and urine samples.

Finally, the new UMMt RevolutioN transport medium enables optimized sample management by preserving specimen integrity up to 72 hours.

Catalogue Number(s)

00060
Product Description: MYCOFAST® RevolutioN
Number of Tests: 25 tests

00061
Product Description: UMMT RevolutioN
Number of Tests: 50 additional transport media

00062
Product Description: 00062 COMPLEMENT MYCOFAST® RevolutioN
Number of Tests: 25 additional test trays

00064
Product Description: Mycoplasma Stabilizer
Number of Tests: 2 x 5 mL (2 x 50 specimens)

Type:

MYCOFAST® Screening RevolutioN – Complement MYCOFAST® RevolutioN

Detection, enumeration, identification and complete antimicrobial susceptibility testing of urogenital mycoplasma: SCREENING METHOD

The MYCOFAST® Screening RevolutioN kit and its Complement MYCOFAST® RevolutioN enable a complete diagnosis in 2 steps for urogenital mycoplasma diagnosis in various clinical specimens. It’s an accurate, cost-effective, easy-to-use colorimetric assay designed for the detection, enumeration, identification and antibiotic susceptibility determination of Ureaplasma urealyticum (U.u.) and Mycoplasma hominis (M.h.) from urogenital specimens.

The MYCOFAST® Screening approach provides the same results than with the direct method (MYCOFAST® RevolutioN) but in an additional 24/48 hours. It can be chosen for economic reasons sometimes, or to reduce operation time on negative specimens.

The screening step (MYCOFAST® Screening RevolutioN) allows the detection and differentiation of U.u. and M.h. after 24/48 hours of incubation. In case of a positive result, the second step (Complement MYCOFAST® RevolutioN) will provide further information.

  • Complete diagnosis in a two-phase approach
  • Antibiotics FULLY compliant with new worldwide recommendations
  • Cost-effective screening in 24 hours
  • Visual colorimetric method, without expert interpretation
  • Specimen preserved up to 72 hours before analysis
  • Ready to use reagents, “all-liquid method”
  • New closing system for secure operation
  • Results in accordance with pathological ratios

Featuring ready-to-use reagents and an “all liquid” method, MYCOFAST® Screening RevolutioN and its Complement MYCOFAST® RevolutioN offer a complete diagnosis of U.u. and M.h. in a flexible 2-steps approach.

Our exclusive growth activator, the M.h. Supplement, guarantees fast and accurate results.
Moreover, the kit enables enumeration of U.u. > 103 UCC/mL which is compliant with pathological thresholds recognized for sperm and urine samples.

Finally, the new UMMt transport medium enables optimized sample management by preserving specimen integrity up to 72 hours.

Catalogue Number(s)

00063
Product Description: MYCOFAST® Screening RevolutioN
Number of Tests: 50 tests (10 trays of 5 x 2 wells) (Detection and differentiation of U.u/M.h

00062
Product Description: Complement MYCOFAST® RevolutioN
Number of Tests: 25 tests (25 trays) (Enumeration/Identification/Antimicrobial susceptibility testing)

00061
Product Description: UMMT RevolutioN
Number of Tests: 50 vials (Transport and inoculation medium)

000064*
Product Description: Mycoplasma Stabilizer
Number of Tests: 2 x 5 mL (2 x 50 specimens)

Type:

A7 Agar

Agar plates for specific culture, enumeration and morphological identification of urogenital mycoplasma.

The A7 Agar enables the culture, semi-quantitative enumeration and the morphological identification (solid method) of Ureaplasma urealyticum (U.u.) and Mycoplasma hominis (M.h.) from endocervical, urethral, urinary and sperm samples, as well as gastric secretions and other samples likely to contain urogenital mycoplasma infection.

Catalogue Number(s)

00090
Product Description: A7 Agar
Number of Tests: 8

Market Segment:
Type:

MYCOFAST® EvolutioN 3

Detection, enumeration, identification and complete antimicrobial susceptibility testing of urogenital mycoplasma: DIRECT METHOD.

The MYCOFAST® EvolutioN 3 kit enables a complete diagnosis for urogenital mycoplasma Ureaplasma urealyticum (U.u.) and Mycoplasma hominis (M.h.) in various clinical specimens. In addition, the MYCOFAST® EvolutioN 3 can be used to determine the susceptibility of U.u and M.h to 7 antibiotics.

  • All-in-one test
  • Ready-to-use reagents, “all-liquid” method
  • High sensitivity and specificity
  • Standardized and approved susceptibility testing
  • Fast results for clinicians, available within 24 hours
  • Visual colorimetric method, without expert interpretation

Featuring ready-to-use reagents and an “all liquid” method, MYCOFAST® EvolutioN 3 identifies the growth of U.u. and M.h. after 24 hours of incubation. Our exclusive growth activator, the M.h. Supplement, guarantees fast and accurate results.

Moreover, MYCOFAST® EvolutioN 3 enables the enumeration of U.u.  > 103 UCC/mL which is compliant with pathological thresholds recognized for sperm and urine samples.

Finally, the new UMMt transport medium enables optimized sample management by preserving specimen integrity up to 72 hours.

Catalogue Number(s)

00036
Product Description: MYCOFAST® EvolutioN 3

00836 (optional)
Product Description: UMMt (3ml)

00064 (optional)
Product Description: MYCOPLASMA Stabilizer

Type:

MYCOFAST® Screening EvolutioN 3

Detection, enumeration, identification and complete antimicrobial susceptibility testing of urogenital mycoplasma: SCREENING METHOD.

The MYCOFAST® Screening EvolutioN 3 kit enables a complete diagnosis in 2 steps for urogenital mycoplasma Ureaplasma urealyticum (U.u.) and Mycoplasma hominis (M.h.) in various clinical specimens. In addition, the MYCOFAST® Screening EvolutioN 3 can be used to determine the susceptibility of U.u and M.h to 7 antibiotics.

MYCOFAST® Screening EvolutioN 3 provides the same results than with the direct method (MYCOFAST® EvolutioN 3) but in an additional 24/48 hours. This approach can be chosen for economic reasons sometimes, or to reduce operation time on negative specimens.

The screening step allows the detection of U.u. and M.h. growth after 24/48 hours of incubation.

In case of a positive result, the second step will provide further results.

  • Ready-to-use reagents, “all-liquid” method
  • High sensitivity and specificity
  • Standardized and approved susceptibility testing
  • Fast results for clinicians, available within 24 hours
  • Visual colorimetric method, without expert interpretation

Our exclusive growth activator, the M.h. Supplement, guarantees fast and accurate results.
Moreover, the kit enables enumeration of U.u.  > 103 UCC/mL which is compliant with pathological thresholds recognized for sperm and urine samples.

Finally, the new UMMt transport medium enables optimized sample management by preserving specimen integrity up to 72 hours.

Catalogue Number(s)

00042
Product Description: MYCOFAST® Screening EvolutioN 3
Number of Tests: 35 tests

00077 (optional)
Product Description: UMMt – UMMlyo (3ml)
Number of Tests: 35 additional tansport and growth media

00836 (optional)
Product Description: UMMt (3ml)
Number of Tests: 35 additional tansport media

00064 (optional)
Product Description: MYCOPLASMA Stabilizer
Number of Tests: 2×5 ml (2×50 specimens)

Type:

Mycoplasma Control

Characterized strains for the Quality Control of urogenital mycoplasma diagnosis.

MYCOPLASMA CONTROL has been created to help laboratories in their daily Quality process.

MYCOPLASMA CONTROL strains have been isolated from clinical specimens, characterized according to standard methods and finally lyophilized.
Our kit contains 6 characterized lyophilized strains of Ureaplasma urealyticum and Mycoplasma hominis (up to 12 tests).

  • Quality control of liquid media methods
  • Meets quality management requirements (compliant with ISO 15189:2007 recommendations)
  • Offers relevant results complying with M.I.C. values (Minimum Inhibitory Concentration) in liquid medium.
  • Compatible with different commercialized methods.

Catalogue Number(s)

00900
Product Description: MYCOPLASMA CONTROL
Number of Tests: 12 tests

Mycoscreen® Plus

Convenient routine test for culture and rapid differential diagnosis of urogenital mycoplasma.

MYCOSCREEN® PLUS enables a simple identification of Ureaplasma urealyticum (U.u.) and Mycoplasma hominis (M.h.).

  • Ready-to-use reagents, “all-liquid” method
  • High sensitivity and specificity
  • Fast results for clinicians, available within 24 hours
  • Visual colorimetric method, without expert interpretation

MYCOSCREEN® PLUS is based on a method that enables the differential diagnosis between commensal U.u and M.h (< 103 CCU/mL) and high titres that could be incriminated in an infectious or super infectious process (> 104 CCU/mL).
This kit must be used in association with the A7 Agar plate (modified Shepard medium) for the enumeration and the microscopical identification of U.u. and M.h.

Featuring ready-to-use reagents and an “all liquid” method, MYCOSCREEN® PLUS identifies U.u. and M.h. growth after 24-hours of incubation given our exclusive growth activator, the “M.h. Supplement”.
The new UMMt transport medium enables optimized sample management by preserving specimen integrity up to 72 hours.

Catalogue Number(s)

00025
Product Description: MYCOSCREEN® PLUS
Number of Tests: 32 tests

Type:

Serology MUG

Complementary immunological test to the direct detection of urogenital mycoplasma.

The SEROLOGY kit enables the quantitative detection in serum of the antibodies against the principal urogenital mycoplasma species, Ureaplasma urealyticum (U.u.) and Mycoplasma hominis (M.h.).

Given their lack of immunogenicity, serological testing of mycoplasmas does not replace direct diagnosis from patient specimens but is a pertinent complementary test. The serologic test for urogenital mycoplasmas is especially use to diagnose a deep genital infection, like salpingitis or prostatitis. The technique of metabolic inhibition using lyophilized reagents and reference strains is the most appropriate technique for use by non-specialized laboratories.

More than being the fastest technology available for Mycoplasma serology testing, our SEROLOGY test offers:

  • Simple methodology with no prior treatment of serum
  • High sensitivity and specificity
  • Fast results for clinicians, available within 24 hours
  • Visual colorimetric method, without expert interpretation
  • Control serum standard included in the kit

Catalogue Number(s)

00014
Product Description: SEROLOGY
Number of Tests: 14 tests

UMMt RevolutioN

Optimized Transport Medium preserving specimen integrity for up to 72h before analysis.

The UMMt RevolutioN medium simplifies the transport and storage of Ureaplasma urealyticum (U.u.) and Mycoplasma hominis (M.h.) present in pathological patient samples.

Given this new generation of UMMt transport medium and our new “MYCOPLASMA Stabilizer”, specimens are preserved up to 72 hours allowing analysis to be outsourced or deferred.

UMMt RevolutioN is:

  • A complement of transport medium for MYCOFAST® RevolutioN (REF 00060).
  • A transport and inoculation medium for MYCOFAST® Screening RevolutioN (REF 00063) and its COMPLEMENT MYCOFAST® RevolutioN (REF 00062)

Catalogue Number(s)

00061
Product Description: UMMt RevolutioN
Number of Tests: 50 vials

00064
Product Description: MYCOPLASMA Stabilizer
Number of Tests: 2 x 5 mL (2 x 50 specimens)

Type: